FA
CELG

Friess Associates’s Celgene Corp CELG Stock Holding History

Friess Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-130,072
Closed -$15.1M – 184
2016
Q4 		$15.1M Buy
+130,072
New +$14.5M 1.48% 30
2015
Q3 		– Sell
-151,910
Closed -$17.6M – 197
2015
Q2 		$17.6M Sell
151,910
-1,774
-1% -$203K 1.47% 21
2015
Q1 		$17.7M Sell
153,684
-77,100
-33% -$9.21M 1.43% 27
2014
Q4 		$25.8M Sell
230,784
-71,685
-24% -$7.56M 2.08% 8
2014
Q3 		$28.7M Sell
302,469
-21
-0% -$1.9K 2.44% 6
2014
Q2 		$26M Sell
302,490
-53,024
-15% -$4.03M 2.12% 4
2014
Q1 		$24.8M Sell
355,514
-32,960
-8% -$2.61M 1.94% 17
2013
Q4 		$32.8M Sell
388,474
-6,480
-2% -$513K 2.47% 6
2013
Q3 		$30.4M Sell
394,954
-207,960
-34% -$14.6M 2.43% 9
2013
Q2 		$35.3M Buy
+602,914
New +$36.3M 2.76% 4

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Friess Associates's CELG Position: Q1 2017 in Review

Friess Associates sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 130,072 shares — an estimated $15.1M sold.

Friess Associates first reported a position in CELG in Q2 2013 and held it in 10 quarters. The position peaked at $35.3M in Q2 2013. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Friess Associates reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
  • Friess Associates sold 130,072 Celgene Corp shares in Q1 2017, an estimated $15.1M.
  • Friess Associates first reported a position in Celgene Corp in Q2 2013 and held it in 10 quarters.
  • Friess Associates's Celgene Corp position peaked at $35.3M in Q2 2013.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Friess Associates's 13F filing for Q1 2017, filed 15 May 2017.